Goldman Sachs’s Insmed INSM Stock Holding History

Goldman Sachs’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.93M	Buy	+83,800	New	+$10.1M	﹤0.01%	3344
2026 Q1	–	Sell	-58,500	Closed	-$10.2M	–	6735
2025 Q4	$10.2M	Sell	58,500 -71,500	-55%	-$13M	﹤0.01%	3084
2025 Q3	$18.7M	Buy	130,000 +30,000	+30%	+$3.68M	﹤0.01%	2328
2025 Q2	$10.1M	Buy	+100,000	New	+$7.65M	﹤0.01%	2750
2025 Q1	–	Sell	-35,300	Closed	-$2.44M	–	6232
2024 Q4	$2.44M	Buy	+35,300	New	+$2.54M	﹤0.01%	4113
2016 Q2	–	Sell	-59,500	Closed	-$754K	–	7128
2016 Q1	$754K	Sell	59,500 -500	-0.8%	-$6.57K	﹤0.01%	4335
2015 Q4	$1.09M	Hold	60,000	–	–	﹤0.01%	4214
2015 Q3	$1.11M	Buy	60,000 +10,000	+20%	+$250K	﹤0.01%	4367
2015 Q2	$1.22M	Buy	+50,000	New	+$1.14M	﹤0.01%	4348
2015 Q1	–	Sell	-49,600	Closed	-$767K	–	7179
2014 Q4	$767K	Buy	+49,600	New	+$704K	﹤0.01%	4863
2014 Q3	–	Sell	-24,400	Closed	-$488K	–	7178
2014 Q2	$488K	Sell	24,400 -757,200	-97%	-$11.2M	﹤0.01%	5344
2014 Q1	$14.9M	Buy	+781,600	New	+$14.9M	﹤0.01%	2012

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Goldman Sachs's INSM Position: Q2 2026 in Review

Goldman Sachs increased its Insmed (INSM) stake by 50% in Q2 2026, buying an estimated $56.6M and bringing the position to 1,409,885 shares worth $150M. The position accounts for 0.01% of the portfolio, ranked #930.

Goldman Sachs first reported a position in INSM in Q3 2013 and has held it in 52 quarters since. The position peaked at $217M in Q4 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Goldman Sachs held 1,409,885 shares of Insmed worth $150M as of Q2 2026.
Goldman Sachs bought 467,239 Insmed shares in Q2 2026, an estimated $56.6M.
Insmed made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #930 holding.
Goldman Sachs first reported a position in Insmed in Q3 2013 and has held it in 52 quarters since.
Goldman Sachs's Insmed position peaked at $217M in Q4 2025.
667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.